Abstract:
Red wines, moderate consumption of which is associated with beneficial effects on health, including a reduced incidence of cardiovascular disease, contain a rich diversity of simple and complex (poly)phenolic compounds. Subtle changes in the polyphenolic profile occur during maturation of the wine which impacts on their colour and taste. Although the protective effects of red wine consumption have been linked with resveratrol and procyanidins, the identity of the compounds involved remains unclear.
Wine is basically fermented grape juice with a minimal alcohol level of 8.5% by volume. The wild grapevine originated in the Far East (Mesopotamia) and Egypt and evidence for wine production dates from Neolithic times. Wine was consumed by many ancient civilisations including the Mesopotamians, Egyptians, Greeks and Romans. Once the floods had receded, Noah appears to have over indulged in wine (Genesis, Chapter IX, Verse 21) and St. Paul apparently recommended the consumption of wine on health grounds. Galileo made and drank his own red wines right up to his death at the age of 78 in 1642. More than 350 years later, there is now a widely held view that moderate red wine consumption, preferably with meals, can have beneficial effects on health with reduced incidences of coronary heart disease, some cancers and possibly even a delayed cognitive decline. There are numerous papers on the subject but what brought the topic to a worldwide audience was a 1991 CBS 2 television programme in the USA, "60 Minutes", in which the epidemiologist Serge Renaud linked moderate consumption of red wine with the relatively low incidence of cardiovascular disease in France despite high consumption of saturated fats -a phenomenon now referred to widely as the "French Paradox". Readers interested in learning more about these events and subsequent research associating the high levels of phenolic and polyphenolic compounds in red wines with their protective effects on health should read Roger Corder's most interesting and informative book "The Wine Diet"
.

Production of wines
A wide variety of processes are used to make red wine. Typically, red grapes of Vitis vinifera are pressed and the juice (must), together with the crushed grapes, undergo alcoholic fermentation for 5-10 days at ca. 25°-28°C. The solids are removed and the young wine subjected to a secondary or malo-lactic fermentation, which results in malic acid being converted to lactic acid and carbon dioxide. This softens the acidity of the wine and adds to its complexity and stability. The red wine is then matured in stainless steel vats, or in the case of higher quality vintages in oak barrels, for varying periods before being filtered and Some of the structures involved in these processes are illustrated in Figure 3 .
When wines are aged in oak barrels or with oak chips, ellagitannins, such as vescalagin, leach from the oak and also form transformation products with anthocyanins.
Because of these processes, levels of the red coloured free anthocyanins decline but they are replaced by the more stable co-pigments with the vescalagin-malvidin-3-O-glucoside hybrid imparting a purple rather than a red colour 4 ( Figure 4 ). The oak-derived ellagitannins also react with flavan-3-ols. Vescalagin and (-)-epicatechin, for instance, yield epiacutissum A (Figure 4 ) which, along with other ellagitannin-flavan-3-ol transformation products, gives the wine a smooth and velvety astringent taste, even at low concentrations, as opposed to the more bitter astringency imparted by procyandins 5 .
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Red wine and antioxidants
The high concentrations of (poly)phenolic compounds result in most red wines having a high antioxidant capacity and in 1993 Frankel et al. reported that red wine phenolics inhibited the oxidation of human low density lipoprotein in vitro 6 . There is now, however, a realisation that the protective effects of red wine phenolics on cardiovascular disease and other age-related chronic conditions, are unlikely to be a consequence of them functioning as antioxidants in vivo. After ingestion, the concentration of their derived metabolites in the circulatory system is much too low to elicit such effects and current research suggests that they influence disease risk via several complementary and overlapping mechanisms with complex interactions between cell signalling pathways 2 .
What compound(s) impart the protective effects of red wine consumption ?
trans-Resveratrol has gained much attention because of its ability to inhibit or retard a wide variety of animal diseases that include cardiovascular disease and cancer. It has also been reported to increase stress resistance and enhance longevity 7 . The protective effects of moderate red wine consumption are regularly attributed to resveratrol in both scientific papers and the popular press. However, this is most improbable as the levels of resveratrol in red wines are so low that for humans to ingest the quantity of resveratrol that affords protective effects in animals they would have to drink in excess of 100 L of red wine per day 8 .
Recent research has linked procyanidins to the reduced incidence of cardiovascular disease associated with moderate red wine consumption. Healthy blood vessels produce small amount of a peptide, endothelin-1, which maintains the integrity of the vessel wall.
Excess endothelin-1 production, however, causes vasoconstriction, hardening of the artery wall and eventually atheroslerosis 9 . Red wine polyphenols suppress the synthesis of endothelin-1 and induce dilatation of blood vessels, an effect that could explain their antiatherosclerotic activity. When the ability of more than 150 red wines to inhibit the synthesis of endothelin-1 by cultured endothelial cells was tested there was a highly significant correlation between bioactivity and the procyanidin content of the wines. Parallel tests with individual compounds revealed that procyanidin hexamers and heptamers inhibited endothelin-1 6 production at low mM concentrations and were much more active in this regard that flavan-3-ol monomers and dimers and other red wine constituents. These findings become especially fascinating when considered along with information gleaned from the French census of 1999 which identified usual patterns of regional ageing with 30% more men over the age of 75 years in the départmente of Gers in the Midi-Pyrenees. Wines produced in this region, principally from Tannat grapes, have an extremely high procyanidin content. As until very recently, consumption of these Tannat wines was almost exclusively local, this provides a most interesting association between male longevity and procyanidin intake Danielle Ryan is a Senior Lecturer in Chemistry at Charles Sturt University. Her research is focussed on the application of analytical chemistry and separation science to complex natural metabolomes (e.g. olive, wine, urine) for the understanding of natural product quality and potential health benefits of bioactive compounds.
